Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 SEK | -9.67% | -14.78% | -66.08% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 109M 1.19B 9.1B |
---|---|---|---|---|---|
Net income 2022 | -76M -831M -6.34B | Net income 2023 | -39M -426M -3.25B | EV / Sales 2022 | - |
Net cash position 2022 | 76.01M 831M 6.34B | Net cash position 2023 | 26.02M 285M 2.17B | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.99
x | P/E ratio 2023 |
-2.78
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.68% |
Latest transcript on Scandion Oncology A/S
1 day | -9.67% | ||
1 week | -14.78% | ||
Current month | -46.02% | ||
1 month | -42.09% | ||
3 months | -65.26% | ||
6 months | +13.11% | ||
Current year | -66.08% |
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 01/17/01 |
Chief Executive Officer | 64 | 02/23/02 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 01/22/01 | |
Director/Board Member | 69 | 07/18/07 | |
Martin Møller
CHM | Chairman | 49 | 01/21/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1.355 | -9.67% | 172 777 |
26/24/26 | 1.5 | +3.45% | 37,251 |
25/24/25 | 1.45 | +4.32% | 40,968 |
24/24/24 | 1.39 | -3.81% | 109,713 |
23/24/23 | 1.445 | -9.12% | 93,277 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 07:59 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.08% | 5.57M | |
-2.37% | 103B | |
+1.63% | 95.28B | |
+2.21% | 22.15B | |
-15.83% | 21.02B | |
-8.26% | 18.15B | |
-41.01% | 16.73B | |
-13.67% | 16.05B | |
+3.89% | 13.68B | |
+34.68% | 12.17B |
- Stock Market
- Equities
- SCOL Stock